BioPace
PrivateLast Round
Grant
Apr 1, 2020
Est. Valuation
$3M
Total Funding Raised
$270,000
Company Overview
BioPace is a biotechnology company developing a hardware-free biological pacemaker technology to complement or replace traditional implantable electronic pacemakers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioPace Comparables
Compare BioPace with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PacingCure B.V. | 82% | |
| Cortex, Inc. | 64% | |
| CAIRDAC | 63% | |
BioPace Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2020 | ||||
| Accelerator | Nov 1, 2013 |
BioPace Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leonhardt Ventures | Accelerator |
| Cal-X Stars Business Accelerator | Accelerator |
| National Institutes of Health (NIH) | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2013
$270K round led by Leonhardt Ventures.
BioPace Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioPace's valuation, stock price, and market status.